Skip to main content
SpringerLink
Log in

Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Objective To determine the value of apparent diffusion coefficient (ADC) histogram parameters for the prediction of individual survival in patients undergoing surgery for recurrent glioblastoma (GBM) in a retrospective cohort study. Methods Thirty-one patients who underwent surgery for first recurrence of a known GBM between 2008 and 2012 were included. The following parameters were collected: age, sex, enhancing tumor size, mean ADC, median ADC, ADC skewness, ADC kurtosis and fifth percentile of the ADC histogram, initial progression free survival (PFS), extent of second resection and further adjuvant treatment. The association of these parameters with survival and PFS after second surgery was analyzed using log-rank test and Cox regression. Results Using log-rank test, ADC histogram skewness of the enhancing tumor was significantly associated with both survival (p = 0.001) and PFS after second surgery (p = 0.005). Further parameters associated with prolonged survival after second surgery were: gross total resection at second surgery (p = 0.026), tumor size (0.040) and third surgery (p = 0.003). In the multivariate Cox analysis, ADC histogram skewness was shown to be an independent prognostic factor for survival after second surgery. Conclusion ADC histogram skewness of the enhancing lesion, enhancing lesion size, third surgery, as well as gross total resection have been shown to be associated with survival following the second surgery. ADC histogram skewness was an independent prognostic factor for survival in the multivariate analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

    Article  CAS  PubMed  Google Scholar 

  2. Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung WK (1999) Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 17:2572–2578

    CAS  PubMed  Google Scholar 

  3. Barker FG, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB (1998) Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42:709–720

    Article  PubMed  Google Scholar 

  4. Barbagallo GMV, Jenkinson MD, Brodbelt AR (2008) “Recurrent” glioblastoma multiforme, when should we reoperate? Br J Neurosurg 22:452–455

    Article  PubMed  Google Scholar 

  5. Pope WB, Lai A, Mehta R et al (2011) apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. Am J Neuroradiol 32:882–889

    Article  CAS  PubMed  Google Scholar 

  6. Ryu YJ, Choi SH, Park SJ, Yun TJ, Kim J-H, Sohn C-H (2014) Glioma: application of whole-tumor texture analysis of diffusion-weighted imaging for the evaluation of tumor heterogeneity. PLoS ONE 9:e108335

    Article  PubMed  PubMed Central  Google Scholar 

  7. Wen Q, Jalilian L, Lupo JM, Molinaro AM, Chang SM, Clarke J, Prados M, Nelson SJ (2014) Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab. J Neurooncol 121:331–339

    Article  PubMed  PubMed Central  Google Scholar 

  8. Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS (2015) Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme. J Neurooncol 123:179–188

    Article  CAS  PubMed  Google Scholar 

  9. Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17:825–841

    Article  PubMed  Google Scholar 

  10. Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143–155

    Article  PubMed  Google Scholar 

  11. Avants BB, Epstein CL, Grossman M, Gee JC (2008) Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal 12:26–41

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhang Y, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20:45–57

    Article  CAS  PubMed  Google Scholar 

  13. Quick J, Gessler F, Dützmann S, Hattingen E, Harter PN, Weise LM, Franz K, Seifert V, Senft C (2014) Benefit of tumor resection for recurrent glioblastoma. J Neurooncol 117:365–372

    Article  CAS  PubMed  Google Scholar 

  14. Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, Lim M, Brem H, Quiñones-Hinojosa A (2013) Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg 118:812–820

    Article  PubMed  PubMed Central  Google Scholar 

  15. Gupta RK, Cloughesy TF, Sinha U, Garakian J, Lazareff J, Rubino G, Rubino L, Becker DP, Vinters HV, Alger JR (2000) Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 50:215–226

    Article  CAS  PubMed  Google Scholar 

  16. Castillo M, Smith JK, Kwock L, Wilber K (2001) Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. Am J Neuroradiol 22:60–64

    CAS  PubMed  Google Scholar 

  17. Pope WB, Kim HJ, Huo J et al (2009) Recurrent glioblastoma multiforme: adc histogram analysis predicts response to bevacizumab treatment. Radiology 252:182–189

    Article  PubMed  Google Scholar 

  18. Asao C, Korogi Y, Kitajima M, Hirai T, Baba Y, Makino K, Kochi M, Morishita S, Yamashita Y (2005) Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. Am J Neuroradiol 26:1455–1460

    PubMed  Google Scholar 

  19. Hu LS, Eschbacher JM, Heiserman JE et al (2012) Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival. Neuro-Oncol 14:919–930

    Article  PubMed  PubMed Central  Google Scholar 

  20. Nowosielski M, Recheis W, Goebel G, Güler Ö, Tinkhauser G, Kostron H, Schocke M, Gotwald T, Stockhammer G, Hutterer M (2011) ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma. Neuroradiology 53:291–302

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ellingson BM, Kim HJ, Woodworth DC, Pope WB, Cloughesy JN, Harris RJ, Lai A, Nghiemphu PL, Cloughesy TF (2014) Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology 271:200–210

    Article  PubMed  PubMed Central  Google Scholar 

  22. Grech-Sollars M, Hales PW, Miyazaki K et al (2015) Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain. NMR Biomed 28:468–485

    Article  PubMed  PubMed Central  Google Scholar 

  23. Doane DP, Seward LE (2011) Measuring skewness: a forgotten statistic. J Stat Educ 19:1–18

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Carl Gustav Carus Faculty of Medicine, Dresden University of Technology, Fetscherstrasse 74, 01307, Dresden, Germany

    Amir Zolal, Tareq A. Juratli, Dino Podlesek, Kerim Hakan Sitoci Ficici, Gabriele Schackert, Stephan B. Sobottka, Bernhard Rieger & Dietmar Krex

  2. Institute for Diagnostic and Interventional Neuroradiology, Carl Gustav Carus Faculty of Medicine, Dresden University of Technology, Fetscherstrasse 74, 01307, Dresden, Germany

    Jennifer Linn & Hagen H. Kitzler

Authors
  1. Amir Zolal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tareq A. Juratli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jennifer Linn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dino Podlesek
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kerim Hakan Sitoci Ficici
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hagen H. Kitzler
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gabriele Schackert
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Stephan B. Sobottka
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bernhard Rieger
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Dietmar Krex
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amir Zolal.

Ethics declarations

Conflict of interest

We declare no conflict of interest.

Informed consent

The institutional ethics committee approved the retrospective study and required no separate informed consent from the participants.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zolal, A., Juratli, T.A., Linn, J. et al. Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery. J Neurooncol 127, 551–557 (2016). https://doi.org/10.1007/s11060-016-2063-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-016-2063-7

Keywords

Search

Navigation